Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 8; no. 1; p. 15273
Main Authors Pegoraro, Stefano, Duffey, Maëlle, Otto, Thomas D, Wang, Yulin, Rösemann, Roman, Baumgartner, Roland, Fehler, Stefanie K, Lucantoni, Leonardo, Avery, Vicky M, Moreno-Sabater, Alicia, Mazier, Dominique, Vial, Henri J, Strobl, Stefan, Sanchez, Cecilia P, Lanzer, Michael
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 06.04.2017
Nature Portfolio
Subjects
Erratum
Malaria
Online AccessGet full text

Cover

More Information
Summary:Nature Communications 8 Article number:14193 (2017); Published 31 January 2017; Updated 6 Apr 2017 This Article contains errors in Figs. 1 and 8 that were introduced during the production process. The compound on the lower right side of Fig. 1 is labelled incorrectly and should be labelled ‘SC83288’. The correct version of Fig.
Bibliography:erratum
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms15273